Adjusting DLCO for Hb and its effects on the Hematopoietic Cell Transplantation-specific Comorbidity Index (Q43657801)

25 November 2017

title

Adjusting DLCO for Hb and its effects on the Hematopoietic Cell Transplantation-specific Comorbidity Index (English)

1 reference

25 November 2017

1 reference

D G Coffey

1

1 reference

25 November 2017

D A Pollyea

2

1 reference

25 November 2017

H Myint

3

1 reference

25 November 2017

C Smith

4

1 reference

25 November 2017

J A Gutman

5

1 reference

25 November 2017

language of work or name

English

0 references

publication date

18 March 2013

1 reference

Bone Marrow Transplantation

25 November 2017

published in

1 reference

25 November 2017

volume

48

1 reference

25 November 2017

issue

9

1 reference

25 November 2017

page(s)

1253-1256

1 reference

Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT

25 November 2017

cites work

1 reference

7 January 2021

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

1 reference

7 January 2021

Allogeneic hematopoietic cell transplantation for chronic myelomonocytic leukemia

1 reference

7 January 2021

Comorbidity and disease status based risk stratification of outcomes among patients with acute myeloid leukemia or myelodysplasia receiving allogeneic hematopoietic cell transplantation.

1 reference

7 January 2021

Comorbidity predicts survival in myelodysplastic syndromes or secondary acute myeloid leukaemia after allogeneic stem cell transplantation.

1 reference

7 January 2021

Outcomes after allogeneic hematopoietic cell transplantation with nonmyeloablative or myeloablative conditioning regimens for treatment of lymphoma and chronic lymphocytic leukemia

1 reference

7 January 2021

The hematopoietic cell transplantation comorbidity index (HCT-CI) predicts clinical outcomes in lymphoma and myeloma patients after reduced-intensity or non-myeloablative allogeneic stem cell transplantation.

1 reference

7 January 2021

Assessment of the hematopoietic cell transplantation comorbidity index in non-Hodgkin lymphoma patients receiving reduced-intensity allogeneic hematopoietic stem cell transplantation

1 reference

7 January 2021

Optimizing patient selection for myeloablative allogeneic hematopoietic cell transplantation in chronic myeloid leukemia in chronic phase.

1 reference

7 January 2021

Hematopoietic cell transplantation specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission: combined FHCRC and MDACC experiences

1 reference

7 January 2021

Long-term outcomes among older patients following nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation for advanced hematologic malignancies

1 reference

7 January 2021

Hematopoietic cell transplantation-comorbidity index and Karnofsky performance status are independent predictors of morbidity and mortality after allogeneic nonmyeloablative hematopoietic cell transplantation

1 reference

7 January 2021

Five-year follow-up of patients with advanced chronic lymphocytic leukemia treated with allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning

1 reference

7 January 2021

The hematopoietic cell transplantation-specific comorbidity index fails to predict outcomes in high-risk AML patients undergoing allogeneic transplantation--investigation of potential limitations of the index

1 reference

7 January 2021

Performance status, but not the hematopoietic cell transplantation comorbidity index (HCT-CI), predicts mortality at a Canadian transplant center.

1 reference

7 January 2021

A modified EBMT risk score and the hematopoietic cell transplantation-specific comorbidity index for pre-transplant risk assessment in adult acute lymphoblastic leukemia

1 reference

7 January 2021

Pretreatment C-reactive protein is a predictor for outcomes after reduced-intensity allogeneic hematopoietic cell transplantation

1 reference

7 January 2021

Impact of comorbidity indexes on non-relapse mortality.

1 reference

7 January 2021

Iron-deficiency anaemia: its effect on transfer factor for the lung (diffusiong capacity) and ventilation and cardiac frequency during sub-maximal exercise

1 reference

7 January 2021

Standardisation of the single-breath determination of carbon monoxide uptake in the lung

1 reference

7 January 2021

Adjustment of DLCO for hemoglobin concentration.

1 reference

7 January 2021

Identifiers

DOI

10.1038/BMT.2013.31

1 reference

Dimensions Publication ID

25 November 2017

1001665325

0 references

1 reference